Charalambos Michaeloudes1, Po-Jui Chang, Mario Petrou, Kian Fan Chung. 1. Experimental Studies, Airway Disease Section, National Heart and Lung Institute, Imperial College London and Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom.
Abstract
RATIONALE: Aberrant airway smooth muscle cell (ASMC) function and overexpression of transforming growth factor (TGF)-β, which modulates ASMC proliferative and inflammatory function and induces oxidant release, are features of asthma. Nuclear factor E2-related factor 2 (Nrf2) activates antioxidant genes conferring protection against oxidative stress. OBJECTIVES: To determine the role of Nrf2 in ASMCs and its modulation by TGF-β, and compare Nrf2 activity in ASMCs from subjects with severe and nonsevere asthma and healthy subjects. METHODS: ASMCs were cultured from airways of subjects without asthma, and from airway biopsies from patients with severe and nonsevere asthma. We studied Nrf2 activation on antioxidant gene expression and proliferation, the effect of TGF-β on Nrf2 transcriptional activity, and the impact of Nrf2 activation on TGF-β–mediated proliferation and IL-6 release. Nrf2–antioxidant response elements binding and Nrf2-dependent antioxidant gene expression was determined in asthmatic ASMCs. MEASUREMENTS AND MAIN RESULTS: Activation of Nrf2 led to up-regulation of the antioxidant genes heme oxygenase (HO)-1, NAD(P)H:quinone oxidoreductase, and manganese superoxide dismutase, and a reduction in proliferation. TGF-β reduced Nrf2-mediated antioxidant gene transcription through induction of activating transcription factor-3 expression. Nrf2 activation attenuated TGF-β–mediated reduction in HO-1,ASMC proliferation, and IL-6 release. Nrf2–antioxidant response elements binding was reduced in ASMCs from patients with severe asthma compared with ASMCs from patients with nonsevere asthma and normal subjects. HO-1 expression was reduced in ASMCs from patients with both nonsevere and severe asthma compared with healthy subjects. CONCLUSIONS: Nrf2 regulates antioxidant responses and proliferation in ASMCs and is inactivated by TGF-β. Nrf2 reduction may underlie compromised antioxidant protection and aberrant ASM function in asthma.
RATIONALE: Aberrant airway smooth muscle cell (ASMC) function and overexpression of transforming growth factor (TGF)-β, which modulates ASMC proliferative and inflammatory function and induces oxidant release, are features of asthma. Nuclear factor E2-related factor 2 (Nrf2) activates antioxidant genes conferring protection against oxidative stress. OBJECTIVES: To determine the role of Nrf2 in ASMCs and its modulation by TGF-β, and compare Nrf2 activity in ASMCs from subjects with severe and nonsevere asthma and healthy subjects. METHODS:ASMCs were cultured from airways of subjects without asthma, and from airway biopsies from patients with severe and nonsevere asthma. We studied Nrf2 activation on antioxidant gene expression and proliferation, the effect of TGF-β on Nrf2 transcriptional activity, and the impact of Nrf2 activation on TGF-β–mediated proliferation and IL-6 release. Nrf2–antioxidant response elements binding and Nrf2-dependent antioxidant gene expression was determined in asthmatic ASMCs. MEASUREMENTS AND MAIN RESULTS: Activation of Nrf2 led to up-regulation of the antioxidant genes heme oxygenase (HO)-1, NAD(P)H:quinone oxidoreductase, and manganese superoxide dismutase, and a reduction in proliferation. TGF-β reduced Nrf2-mediated antioxidant gene transcription through induction of activating transcription factor-3 expression. Nrf2 activation attenuated TGF-β–mediated reduction in HO-1,ASMC proliferation, and IL-6 release. Nrf2–antioxidant response elements binding was reduced in ASMCs from patients with severe asthma compared with ASMCs from patients with nonsevere asthma and normal subjects. HO-1 expression was reduced in ASMCs from patients with both nonsevere and severe asthma compared with healthy subjects. CONCLUSIONS:Nrf2 regulates antioxidant responses and proliferation in ASMCs and is inactivated by TGF-β. Nrf2 reduction may underlie compromised antioxidant protection and aberrant ASM function in asthma.
Authors: Suzy A A Comhair; Kristin S Ricci; Mercedes Arroliga; Abigail R Lara; Raed A Dweik; Wei Song; Stanley L Hazen; Eugene R Bleecker; William W Busse; Kian Fan Chung; Benjamin Gaston; Annette Hastie; Mark Hew; Nizar Jarjour; Wendy Moore; Stephen Peters; W Gerald Teague; Sally E Wenzel; Serpil C Erzurum Journal: Am J Respir Crit Care Med Date: 2005-05-05 Impact factor: 21.405
Authors: Adam M Goldsmith; J Kelley Bentley; Limei Zhou; Yue Jia; Khalil N Bitar; Diane C Fingar; Marc B Hershenson Journal: Am J Respir Cell Mol Biol Date: 2005-10-20 Impact factor: 6.914
Authors: Andrei V Bakin; Nina V Stourman; Konjeti R Sekhar; Cammie Rinehart; Xuexian Yan; Michael J Meredith; Carlos L Arteaga; Michael L Freeman Journal: Free Radic Biol Med Date: 2005-02-01 Impact factor: 7.376
Authors: Mark Hew; Pankaj Bhavsar; Alfons Torrego; Sally Meah; Nadia Khorasani; Peter J Barnes; Ian Adcock; Kian Fan Chung Journal: Am J Respir Crit Care Med Date: 2006-04-13 Impact factor: 21.405
Authors: Shaoping Xie; Razao Issa; Maria B Sukkar; Ute Oltmanns; Pankaj K Bhavsar; Alberto Papi; Gaetano Caramori; Ian Adcock; K Fan Chung Journal: Respir Res Date: 2005-12-16
Authors: Tirumalai Rangasamy; Jia Guo; Wayne A Mitzner; Jessica Roman; Anju Singh; Allison D Fryer; Masayuki Yamamoto; Thomas W Kensler; Rubin M Tuder; Steve N Georas; Shyam Biswal Journal: J Exp Med Date: 2005-07-04 Impact factor: 14.307
Authors: Sheena D Brown; Katherine M Baxter; Susan T Stephenson; Annette M Esper; Lou Ann S Brown; Anne M Fitzpatrick Journal: J Allergy Clin Immunol Date: 2011-12-28 Impact factor: 10.793
Authors: Deepthi Kolli; Meera R Gupta; Elena Sbrana; Thangam S Velayutham; Hong Chao; Antonella Casola; Roberto P Garofalo Journal: Am J Respir Cell Mol Biol Date: 2014-10 Impact factor: 6.914
Authors: Mitchell D Cohen; Joshua M Vaughan; Brittany Garrett; Colette Prophete; Lori Horton; Maureen Sisco; Urmila P Kodavanti; William O Ward; Richard E Peltier; Judith Zelikoff; Lung-chi Chen Journal: J Immunotoxicol Date: 2014-06-09 Impact factor: 3.000
Authors: Mark M Perry; Josie E Baker; David S Gibeon; Ian M Adcock; Kian Fan Chung Journal: Am J Respir Cell Mol Biol Date: 2014-01 Impact factor: 6.914
Authors: Thomas E Sussan; Sachin Gajghate; Samit Chatterjee; Pooja Mandke; Sarah McCormick; Kuladeep Sudini; Sarvesh Kumar; Patrick N Breysse; Gregory B Diette; Venkataramana K Sidhaye; Shyam Biswal Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-05-08 Impact factor: 5.464